Navigation Links
Two Laser Balloon 'Live Cases' Shed New Light on Direct Visualization and PV Ablation
Date:1/24/2011

MARLBOROUGH, Mass., Jan. 24, 2011 /PRNewswire/ -- CardioFocus announced that two "live cases" using its Endoscopic Ablation System were recently conducted. The first live case was a satellite transmission performed at Centro Cardiologico Monzino in Milan, Italy; broadcast to the 16th Annual Boston Symposium on Atrial Fibrillation in Boston, MA. Several pioneers in the treatment of atrial fibrillation served as moderators for this exciting educational presentation, providing perspective on ablation procedures designed to isolate pulmonary veins.

The second live case was performed at St. Georg Hospital, in Hamburg, Germany, by Prof. Karl-Heinz Kuck. Both cases demonstrate the continued interest of leading catheter ablation experts to gain a real time view of the anatomy they are treating to enable durable PV isolation.

Stephen Sagon, CEO of CardioFocus said, "These back-to-back live cases provide CardioFocus with a unique opportunity to be seen by clinicians from around the world. Now that we have CE Mark approval for the latest version of our equipment, we have received requests from multiple, well-respected international arrhythmia centers. We plan to continue our highly disciplined launch of the Endoscopic Ablation System at key European sites in 2011."

The acute isolation rate of pulmonary veins has been reported by CardioFocus clinical investigators at over 99% in peer reviewed articles. While nearly all of the pulmonary veins were isolated during the procedure, 78% of veins were isolated on the very first attempt. Chronic PV isolation was reported to approach 90% when assessed at 3 months. According to Burke Barrett, CardioFocus Vice President of Clinical and Regulatory Affairs, "We expect more scientific studies and further presentations on our Endoscopic Ablation System technology throughout the year, including the  company's US IDE pivotal study in the first half of 2011."

Two years after the initiation of clinical research, approximately 250 patients have been treated under multiple research protocols at 16 different medical centers world-wide. More than 150 patients were treated in the EU and almost 100 patients were enrolled in a US feasibility clinical trial.

The information in this news release related to our product is preliminary and investigative. The CardioFocus System is not approved by the FDA, and no conclusions can or should be drawn regarding its safety or effectiveness.CONTACT: CardioFocus, Marlborough MA, USAMaria Shepherd +1 (617) 548-9892 (media)
'/>"/>

SOURCE CardioFocus
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Philadelphias Victoria A. Cirillo-Hyland, M.D. Adds Alma Lasers Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients
2. Advanced Laser Therapy Solutions for Womens Hair Loss
3. PhotoMedex Launches New Patient-Focused XTRAC Laser Website
4. Alma Lasers Introduces Soprano(XLi) Next Generation Diode Laser Technology
5. Baltimores Mark E. Spier, DPM, Announces FDA Clearance of PinPointe™ FootLaser™ for Treatment of Nail Fungus
6. Alma Lasers Joins the Fight Against Breast Cancer with the Launch of the NEW SopranoXLi
7. Solta Medical Announces FDA 510(k) Clearance of Fraxel re:store Dual Laser System for the Treatment of Actinic Keratosis
8. Medical Website Design Experts Aurora Information Technology Introduces Its Newest Website Launch, Muscat Eye Laser Center
9. Block Engineering Introduces Family of Quantum Cascade Laser Mid-IR Spectrometers
10. Chula Vistas Dr. Peter Rullan Adds Alma Lasers Pixel CO2 Laser System to Offer Fractional CO2 Laser Treatments to Patients
11. IRIDEX Granted U.S. Patent for Adjustable Laser Probe for Eye Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Consumers have taken ... regulators/payers have placed more emphasis on patient outcomes. ... support programs in the pharmaceutical industry have evolved ... Consequently, pharmaceutical companies are focusing on becoming more ... providing products and services that improve health. ...
(Date:6/24/2016)... 24, 2016  Global Blood Therapeutics, Inc. (GBT) (NASDAQ: ... novel therapeutics for the treatment of grievous blood-based ... closing of its previously announced underwritten public offering ... public offering price of $18.75 per share. All ... by GBT. GBT estimates net proceeds from the ...
(Date:6/24/2016)... Dublin ... of the " Global Markets for Spectroscopy Equipment" ... This report focuses on the global ... including its applications in various applications. The report deals ... three main industries: pharmaceutical and biotechnology, food and beverage, ...
Breaking Medicine Technology:
(Date:6/26/2016)... North Carolina (PRWEB) , ... June 26, 2016 , ... ... release of a new product that was developed to enhance the health of felines. ... for centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):